Zelenaia, Olga
The University of Sydney · Children's Hospital of Philadelphia · University of Mississippi · Spark Therapeutics (United States) · University of Pennsylvania
8 papers on CoChat
Most cited papers
- Verified
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine
Retinal Development and DisordersVirus-based gene therapy research
Cited by 2,145
- Verified
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet
Retinal Development and DisordersVirus-based gene therapy research
Cited by 865
- Verified
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
George, L. A., Sullivan, S. K., Giermasz, A., Rasko, J. E. J., Samelson-Jones, B. J., Ducore, J., Cuker, A., Sullivan, L. M., Majumdar, S., Teitel, J., et al. (2017) · New England Journal of Medicine
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 762
- Verified
Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons.
Schlag, B. D., Vondrasek, J. R., Munir, M., Kalandadze, A., Zelenaia, O. A., Rothstein, J. D., & Robinson, M. B. (1998) · Molecular Pharmacology
Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and Metabolism
Cited by 303
- Verified · note
Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer
Bennicelli, J., Wright, J. F., Komaromy, A., Jacobs, J. B., Hauck, B., Zelenaia, O., Mingozzi, F., Hui, D., Chung, D., Rex, T. S., et al. (2008) · Molecular Therapy
Retinal Development and DisordersVirus-based gene therapy research
Cited by 267
- Verified
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material
Lock, M., McGorray, S., Auricchio, A., Ayuso, E., Beecham, E. J., Blouin-Tavel, V., Bosch, F., Bose, M., Byrne, B. J., Caton, T., et al. (2010) · Human Gene Therapy
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Cited by 131
- Verified
Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responses
Hauck, B., Murphy, S. L., Smith, P. H., Qu, G., Liu, X., Zelenaia, O., Mingozzi, F., Sommer, J. M., High, K. A., & Wright, J. F. (2009) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 88
- Verified
Vector characterization methods for quality control testing of recombinant adeno-associated viruses
Wright, J. F., & Zelenaia, O. (2011) · Methods in Molecular Biology
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free